DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 67,368 shares of the medical instruments supplier’s stock after selling 1,420 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in DENTSPLY SIRONA were worth $1,278,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Pacer Advisors Inc. lifted its stake in DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after buying an additional 4,473,972 shares during the last quarter. Nuance Investments LLC boosted its stake in DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after purchasing an additional 2,708,097 shares during the period. Norges Bank bought a new position in DENTSPLY SIRONA in the 4th quarter worth about $45,730,000. Cooke & Bieler LP increased its stake in shares of DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock valued at $174,101,000 after purchasing an additional 1,794,391 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in shares of DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after buying an additional 1,244,326 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.52% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $13.75 on Monday. The stock has a market capitalization of $2.74 billion, a P/E ratio of -6.64, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The business’s fifty day moving average is $15.09 and its two-hundred day moving average is $18.25. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $31.00.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.65%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is -14.07%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on XRAY shares. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Evercore ISI reissued an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Wells Fargo & Company reduced their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. Mizuho lowered their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research note on Thursday, March 13th. Finally, Barrington Research cut their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Thirteen analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $22.58.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.